respiratori
tract
infect
lead
caus
hospit
admiss
morbid
mortal
present
etiolog
agent
respiratori
tract
infect
identifi
sole
base
clinic
sign
symptom
therefor
await
microbiolog
confirm
empir
antibiot
antivir
treatment
initi
base
sever
score
influenza
season
sinc
minor
infect
caus
bacteria
empir
antibiot
treatment
approach
redund
lead
increas
antibiot
resist
moreov
empir
isol
precaut
instal
protect
patient
healthcar
worker
possibl
viral
infect
altogeth
need
rapid
identif
exclus
viral
respiratori
tract
infect
reduc
inappropri
unnecessari
hospit
hygien
intervent
focu
shorten
antibacterialantivir
treatment
current
diagnosi
respiratori
infect
usual
base
combin
molecular
amplif
method
bacteri
cultur
laboratori
laboratorydevelop
realtim
polymeras
chain
reaction
pcr
multiplex
assay
ldt
use
show
excel
sensit
specif
howev
approach
limit
number
target
per
multiplex
reaction
need
batchwis
test
assay
perform
daili
time
result
approxim
h
recent
respiratori
pathogen
rp
panel
genmark
diagnost
carlsbad
ca
usa
becom
avail
detect
extens
panel
respiratori
pathogen
respiratori
virus
three
bacteri
speci
see
method
section
use
esensor
technolog
test
cartridgebas
molecular
assay
use
platform
time
result
approxim
min
show
concord
compar
ldt
hypothet
rp
panel
test
repres
consider
reduct
time
diagnosi
compar
ldt
could
signific
clinic
benefit
paper
pilot
studi
report
analyz
implic
use
rp
panel
detect
respiratori
infect
compar
ldt
regard
time
result
isol
precaut
antibacterialantivir
therapi
primari
endpoint
studi
time
result
rp
panel
compar
ldt
rp
panel
offer
pilot
elev
pressur
droplet
isol
room
thu
isol
discontinu
base
rp
panel
result
due
pilot
natur
studi
antibacteri
antivir
treatment
adjust
base
rp
panel
result
therefor
theoret
time
reduct
treatment
calcul
use
time
result
rp
panel
ldt
secondari
outcom
measur
reduct
isol
day
base
rp
panel
ahead
ldt
result
theoret
reduct
hour
oseltamivir
atyp
pneumonia
treatment
calcul
time
result
ldt
rp
panel
possibl
addit
diagnosi
found
rp
panel
ldt
viral
test
test
mycoplasma
pneumonia
chlamydia
pneumonia
chlamydia
psittaci
perform
day
sampl
arriv
laboratori
sampl
arriv
laboratori
pm
test
legionella
pneumophila
bordetella
parapertussi
follow
day
assay
perform
daili
monday
till
friday
request
weekend
day
viral
respiratori
panel
ldt
consist
adenoviru
bocaviru
coronaviru
coronaviru
coronaviru
coronaviru
influenza
influenza
b
human
metapneumoviru
parainfluenza
differenti
differ
label
probe
respiratori
syncyti
viru
rhinoviru
addit
test
bacteri
pathogen
could
request
legionella
speci
legionella
pneumophila
mycoplasma
pneumonia
chlamydia
pneumonia
chlamydia
psittaci
bordetella
pertussi
bordetella
parapertussi
sputa
sampl
dilut
phosphatebuff
salin
pb
homogen
beadbeat
prior
extract
respiratori
sampl
use
extract
total
nucleic
acid
use
total
nucleic
acid
extract
kit
magna
pure
lc
system
roch
diagnost
nucleic
acid
amplif
detect
realtim
pcr
perform
biorad
thermocycl
use
primer
probe
condit
describ
previous
detect
mycoplasma
pneumonia
chlamydia
pneumonia
chlamydia
psittaci
bcap
assay
biolegio
nijmegen
netherland
develop
bdmax
system
use
test
respiratori
sampl
accord
manufactur
instruct
ldt
result
report
electron
patient
record
time
result
ldt
calcul
time
receipt
sampl
laboratori
time
result
avail
electron
patient
record
specimen
diagnosi
use
ceivd
clear
rp
panel
accept
weekday
pm
test
day
soon
possibl
rp
panel
offer
weekend
treatment
adjust
base
result
rp
panel
use
studi
abl
detect
adenoviru
bocaviru
coronaviru
coronaviru
coronaviru
coronaviru
influenza
influenza
influenza
influenza
b
metapneumoviru
middl
east
respiratori
syndrom
coronaviru
parainfluenza
respiratori
syncyti
viru
b
rhinovirusenteroviru
bordetella
pertussi
legionella
pneumophila
mycoplasma
pneumonia
ldt
sputa
sampl
dilut
dilut
use
pb
accord
manufactur
instruct
respiratori
sampl
pipet
buffer
tube
vortex
transfer
eplex
cartridg
subsequ
eplex
tower
test
gave
invalid
result
run
repeat
result
report
telephon
request
physician
sinc
result
report
electron
patient
record
time
result
calcul
time
receipt
sampl
time
result
report
telephon
time
result
compar
wilcoxon
signedrank
test
use
ibm
spss
statist
version
softwar
window
pvalu
consid
statist
signific
januari
march
patient
includ
symptom
acut
respiratori
infect
whose
characterist
summar
tabl
total
sampl
test
compris
throat
swab
sputum
sampl
nasal
lavag
four
nasopharyng
swab
thirtyfour
test
posit
respiratori
pathogen
one
assay
six
sampl
fail
rp
panel
two
gave
valid
result
upon
retest
four
retest
two
insuffici
remain
sampl
volum
fail
sampl
retest
exclud
analysi
leav
sampl
patient
analysi
none
sampl
fail
ldt
sampl
test
posit
total
pathogen
ldt
rp
panel
tabl
use
ldt
test
posit
neg
wherea
use
rp
panel
shown
tabl
discord
result
found
five
sampl
three
patient
differ
sampl
type
test
tabl
first
sputum
throat
swab
collect
first
test
ldt
posit
influenza
second
test
rhinoviru
posit
nasal
lavag
ldt
neg
sputum
third
patient
sputum
throat
swab
test
sputum
test
coronaviru
posit
sampl
time
accept
time
result
record
calcul
time
result
significantli
shorter
approxim
h
rp
panel
ldt
p
tabl
time
result
h
seen
ldt
sampl
arriv
friday
test
monday
two
remain
sampl
delay
request
author
test
subsequ
rp
panel
four
sampl
time
result
h
two
sampl
alreadi
laboratori
sever
hour
rp
panel
test
request
test
two
sampl
request
pm
therefor
perform
next
day
one
due
failur
initi
sampl
patient
includ
analysi
admit
hospit
time
respiratori
test
request
fiftyon
hospit
patient
isol
await
test
result
wherea
nine
patient
admit
isol
case
isol
instal
mainli
low
clinic
suspicion
pathogen
requir
isol
one
nine
patient
need
isol
sinc
rp
panel
test
posit
influenza
day
ahead
ldt
test
show
patient
admit
isol
respiratori
pathogen
requir
isol
remain
patient
one
die
test
result
becam
avail
one
patient
durat
isol
unknown
leav
patient
analysi
isol
discontinu
base
rp
panel
result
ahead
ldt
result
result
total
reduct
isol
day
median
reduct
day
rang
day
per
patient
eight
remain
patient
isol
discontinu
ldt
result
becam
avail
eight
patient
three
children
isol
withdrawn
moment
ldt
result
report
total
patient
receiv
antivir
antibacteri
treatment
hospit
oseltamivir
treatment
initi
patient
await
test
result
five
test
posit
influenza
influenza
rp
panel
neg
patient
oseltamivir
could
stop
approxim
one
day
earlier
median
h
rang
base
rp
result
compar
ldt
tabl
total
patient
test
influenza
posit
remain
six
receiv
oseltamivir
time
diagnosi
one
patient
oseltamivir
treatment
start
soon
rp
panel
show
influenza
one
day
prior
ldt
result
one
patient
start
ldt
posit
four
patient
receiv
antivir
treatment
two
alreadi
dismiss
time
definit
ldt
diagnosi
await
test
result
patient
receiv
antibiot
treatment
bacteria
caus
atyp
pneumonia
none
patient
either
rp
panel
ldt
eight
test
posit
bordetella
pertussi
legionella
pneumophila
mycoplasma
pneumonia
theori
patient
median
durat
h
rang
antibiot
treatment
atyp
pneumonia
could
save
treatment
stop
rp
panel
test
neg
patient
two
test
posit
rp
panel
bacteri
agent
one
bordetella
pertussi
one
mycoplasma
pneumonia
patient
test
pathogen
request
clinician
consequ
includ
routin
diagnost
ldt
workflow
posit
rp
panel
result
confirm
ldt
quantif
cycl
cq
valu
b
pertussi
pneumonia
respect
ldt
atyp
bacteri
pathogen
mycoplasma
pneumonia
chlamydia
pneumonia
chlamydia
psittaci
request
patient
legionella
ldt
request
ten
patient
hypothes
diagnosi
rp
assay
significantli
reduc
time
result
median
h
compar
batchwis
ldt
consequ
total
isol
day
save
three
day
influenza
exposur
prevent
unnecessari
oseltamivir
treatment
could
shorten
least
h
patient
antibiot
treatment
atyp
pneumonia
median
h
patient
proper
therapeut
isol
measur
could
instal
two
patient
bacteri
pathogen
base
rp
panel
detect
consid
treat
physician
therefor
analyz
routin
ldt
knowledg
studi
first
report
use
rp
panel
clinic
set
demonstr
signific
time
reduct
reflect
previou
clinic
studi
implement
rapid
molecular
test
significantli
reduc
number
isol
day
furthermor
confirm
singl
viral
caus
infect
cohort
patient
enabl
cohort
nurs
increas
number
isol
room
avail
patient
await
identif
respiratori
pathogen
effici
use
isol
room
essenti
influenza
season
demand
room
high
rapid
rp
panel
result
could
result
reduct
oseltamivir
usag
line
previou
studi
result
regard
reduct
antibiot
treatment
atyp
pneumonia
interpret
care
accord
dutch
guidelin
indic
legionella
pneumophila
highrisk
popul
also
stop
base
neg
urin
antigen
test
lack
routin
test
atyp
respiratori
bacteri
pathogen
mostli
legionella
pneumophila
find
addit
respiratori
pathogen
initi
consid
clinician
underlin
import
syndrom
respiratori
test
studi
number
limit
first
clinic
impact
pilot
studi
hamper
design
sinc
rp
assay
readili
offer
reduc
quest
isol
room
coincid
influenza
respiratori
syncyti
viru
epidem
earli
test
result
yet
shown
hospit
inform
system
report
phone
creat
bia
moreov
rp
panel
result
report
provision
result
await
routin
ldt
confirm
delay
show
test
result
electron
patient
record
might
withheld
clinician
discontinu
isol
therefor
creat
underestim
true
clinic
potenti
furthermor
find
studi
extrapol
readili
sinc
singlecent
studi
part
one
winter
season
benefit
rapid
diagnost
might
pronounc
assess
complet
respiratori
season
far
rp
panel
ceivd
clear
nasopharyng
swab
howev
especi
sampl
lower
respiratori
tract
sputum
bronchoalveolar
lavag
import
includ
ceivd
clearanc
sinc
studi
show
sampl
might
higher
diagnost
yield
howev
previou
current
studi
sever
differ
sampl
type
test
good
result
nevertheless
rp
panel
failur
rate
nearli
two
case
due
intern
control
failur
none
ldt
fail
overal
rp
panel
result
show
excel
concord
ldt
three
ldt
posit
cq
valu
could
detect
use
rp
panel
line
previou
find
report
nijhui
et
al
rp
panel
base
syndrom
test
standard
panel
contain
common
respiratori
pathogen
request
physician
howev
rp
panel
complet
especi
care
immunocompromis
patient
case
addit
ldt
test
legionella
speci
cytomegaloviru
herpesviru
toxoplasmosi
fungal
pathogen
would
still
necessari
compar
ldt
rp
panel
test
expens
regard
reagent
consum
cheaper
respect
handson
time
addit
rapid
diagnost
result
cost
reduct
clinic
depart
demonstr
previous
conclus
diagnosi
respiratori
infect
rp
assay
result
signific
reduct
time
result
compar
ldt
caus
reduct
isol
day
theoret
improv
treatment
regimen
advantag
assum
rapid
diagnost
molecular
assay
ad
valu
ongo
improv
patient
care
